StockData
Schrodinger, Inc. logo

Schrodinger, Inc. (SDGR) stock

SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3044% above fair value
$27.20+1.54 (+6.00%)

Close on Nov 18, 2026Market cap $2.03BP/E –Yield –

Schrodinger shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Schrodinger's shares outstanding was 76M at Jun 30, 2026. For fiscal 2025 it was 73M, up 1.1% from the year before. The highest annual figure on record is 75M in fiscal 2023.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202573M+1.1%
FY2024Dec 31, 202473M-3.1%
FY2023Dec 31, 202375M+5.4%
FY2022Dec 31, 202271M+0.8%
FY2021Dec 31, 202171M+17.6%
FY2020Dec 31, 202060M+899.7%
FY2019Dec 31, 20196M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202676M+3.2%
Q1 FY2026Mar 31, 202674M+1.3%
Q4 FY2025Dec 31, 202574M+1.1%
Q3 FY2025Sep 30, 202574M+1.1%
Q2 FY2025Jun 30, 202573M+1.0%
Q1 FY2025Mar 31, 202573M+1.1%
Q4 FY2024Dec 31, 202473M-2.9%
Q3 FY2024Sep 30, 202473M+1.2%
Q2 FY2024Jun 30, 202473M-3.1%
Q1 FY2024Mar 31, 202472M-2.1%
Q4 FY2023Dec 31, 202375M+5.3%
Q3 FY2023Sep 30, 202372M+1.0%
Q2 FY2023Jun 30, 202375M+5.5%
Q1 FY2023Mar 31, 202374M+3.9%
Q4 FY2022Dec 31, 202271M+0.5%
Q3 FY2022Sep 30, 202271M+0.6%
Q2 FY2022Jun 30, 202271M+0.8%
Q1 FY2022Mar 31, 202271M+1.4%
Q4 FY2021Dec 31, 202171M+1.8%
Q3 FY2021Sep 30, 202171M-2.6%
Q2 FY2021Jun 30, 202171M+11.5%
Q1 FY2021Mar 31, 202170M+72.3%
Q4 FY2020Dec 31, 202070M+55.3%
Q3 FY2020Sep 30, 202073M+63.4%
Q2 FY2020Jun 30, 202063M+965.9%
Q1 FY2020Mar 31, 202041M–
Q3 FY2019Sep 30, 201945M–
Q2 FY2019Jun 30, 201944M–
Q1 FY2019Mar 31, 20196M–

More Schrodinger figures

See a number that looks wrong?